pSivida Corp. Stock Nasdaq

Stocks

16-08-09	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
16-07-14	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
16-05-02	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
15-09-28	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
15-09-14	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
WUXI APPTEC CO., LTD.	-0.70%	-4.28%	+52.62%	+86.42%	71.81B
ARGENX SE	+0.45%	-0.82%	+38.81%	+84.19%	60.06B
WUXI BIOLOGICS (CAYMAN) INC.	+4.21%	+5.68%	+36.16%	+25.53%	27.93B
INSMED INCORPORATED	-1.73%	-4.30%	-18.37%	+357.94%	25.7B
BIONTECH SE	-0.51%	-2.28%	+0.48%	-9.27%	24.89B
GENMAB A/S	+0.65%	+1.67%	+26.47%	-7.62%	20.92B
PHARMAESSENTIA CORPORATION	+3.46%	+3.02%	+158.90%	+337.81%	15.04B
EXELIXIS, INC.	+0.48%	+0.86%	+44.56%	+168.42%	14.46B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+3.64%	+1.66%	-4.47%	+524.68%	13.87B
Average	+0.93%	-1.38%	+37.24%	+174.24%	30.52B
Weighted average by Cap.	+0.60%	-1.84%	+37.08%	+129.53%

Employees

Sector